Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare and Fitness
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 17220 times
PR Category : Healthcare and Fitness
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Dairy Has the Nutritional Credentials to Meet Snacking Boom ...
Next Story : InterSystems Wins Two 2020 Best in KLAS Awards
Email this article Print this article

Share this article with your friends and followers
NewsVine
 
 
Most Viewed Press Release posted in the last 7 days
Air Cargo Demand up 9.8% in October 2024 - 15th Month of Consecutive Growth [37663-Views]
Hexagon Phantom Fall/Winter 2024 Watches Collection [34907-Views]
Enter Your High-Shine Era with the New SHEGLAM Crystal Jelly Glaze Stick [29397-Views]
Global Manufacturing and Industrialisation Summit to take place during Abu Dhabi Business ... [18466-Views]
Arabian Center to celebrate the 53rd UAE Eid Al Etihad with fun-filled activities [15941-Views]
Tanishq unveils its largest flagship boutique in Dubai Gold Souk Extension– setting a new ... [9168-Views]
EDGE to Provide Advanced Secure Communications System for the Brazilian Ministry of Defenc... [8844-Views]
UAE Showcased Exceptional Young Talent and Innovation in Debut Participation at 9th BRICS ... [8372-Views]
Statement by H.E. Younis Haji AlKhoori, Undersecretary of the Ministry of Finance on Comme... [7823-Views]
Millennium Place Barsha Heights' award winning “Hospitality Ninjas” kids camp makes a Chri... [7499-Views]
Abu Dhabi Investment Office, Abu Dhabi Civil Defence Authority, and Ambipar sign MoU to en... [7495-Views]
Yas All In: A Weekend Of Racing, Entertainment, And Adventure Across The Whole Of Abu Dhab... [6777-Views]
Up To 90 Per Cent Off Fashion, Electronics, Home, And More: Dubai's 3 Day Super Sale Unvei... [6679-Views]
Mohamed bin Hadi Al Hussaini Discusses Financial Cooperation with Jordan's Minister of Fin... [6552-Views]
As part of The Big 5 Global exhibition Dubai Land Department strengthens its leadership in... [6511-Views]
IBA Champions' Night, Ordinary Congress and Global Boxing Forum to take place in Dubai on ... [6498-Views]
OBJET D'ART Armoriale Répétition Mystérieuse [6088-Views]
Shop & Win Rewards, Dubai Shopping Festival Celebrates 30 Years of with AED 1 Million Cash... [5539-Views]
Dubai Customs Marks UAE's 53rd Eid Al Etihad (Union Day) with Vibrant Celebrations [5531-Views]
e& UAE launches Kids SIM Card and Parental Control Service for safer digital environment f... [5371-Views]
Younis Haji AlKhoori: Eid Al Etihad 53 is Treasured Occasion to Honour Our Nation and Reaf... [5330-Views]
Celebrate 30 Years of DSF with DJG's AED 1.5 million in Gold Prizes [4961-Views]
$1.7 Billion in Airline Funds Blocked by Governments [4469-Views]
Celebrate the Festive Season at Town Centre Jumeirah: Santa is Coming to Town! [4334-Views]
Ferrari celebrates 30 years in the middle east with six unique Ferrari 296 GTBS [4301-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Back to Section Home

Related Stories

 
Top Sections
 
Top Stories